ProfessorCarol Pollock

Hydralazine as a potential novel therapy for maternal obesity and obesity-related kidney disease

Incretin-Based Therapy as Adjunctive Treatment for Type 1 Diabetes with Concurrent Overweight or Obesity

Innovative therapeutic approaches for Chronic Kidney Disease

Modifying the gut microbiome in diabetic kidney disease

Novel anti-fibrotic agents in acute and chronic kidney disease

Novel biomarkers and a unique therapeutic strategy for the treatment of chronic kidney disease

Novel Therapeutic Strategies for Chronic Kidney Disease

Ontogeny of renal microvasculature and aberrant development after preterm birth

Promoting renal fibroblast’s tissue repair and regeneration functions to cure chronic kidney disease

Restoration of Aldh1a2 Function to Exert Anti-Inflammatory and Anti-Fibrotic Roles in Kidney Injury

Stem Cell-derived exosomes prevent the development of diabetic kidney diseases through blocking the function of YAP1

Targeting receptor-interacting serine/threonine-protein kinase (RIPK)3 in renal tubulointerstitial fibrosis

The Effect of Metformin on Inflammatory and Fibrotic Responses in Renal Fibrosis

The impact of inflammation, oxidative stress and metabolic dysregulation in maternal obesity, diabetes and pregnancy

The roles of SIRT1 in metabolic disorders induced by maternal obesity

Ultrasound Assessment of Kidney Transplant Blood Flow

Using stem cells for the treatment of acute kidney injury

Validation of novel non-invasive diagnostic and prognostic methods in chronic kidney disease and kidney transplantation